Lido Advisors LLC purchased a new stake in Tenet Healthcare Corporation (NYSE:THC – Free Report) in the 3rd quarter, Holdings Channel reports. The fund purchased 2,605 shares of the company’s stock, valued at approximately $666,000.
A number of other institutional investors have also recently modified their holdings of THC. Talon Private Wealth LLC lifted its stake in shares of Tenet Healthcare by 35.4% in the 2nd quarter. Talon Private Wealth LLC now owns 23,097 shares of the company’s stock worth $4,321,000 after purchasing an additional 6,044 shares during the period. Counterpoint Mutual Funds LLC bought a new stake in Tenet Healthcare during the third quarter valued at approximately $9,593,000. CX Institutional purchased a new stake in Tenet Healthcare during the third quarter valued at approximately $6,415,000. Public Employees Retirement System of Ohio bought a new position in Tenet Healthcare in the second quarter worth approximately $10,144,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Tenet Healthcare during the 2nd quarter worth $5,504,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
THC has been the subject of a number of recent research reports. Zacks Research downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 29th. Raymond James Financial reiterated an “outperform” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Friday, August 14th. Wells Fargo & Company boosted their price target on Tenet Healthcare from $281.00 to $321.00 and gave the company an “overweight” rating in a report on Monday, November 2nd. Morgan Stanley upped their price target on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday, July 27th. Finally, Stephens reaffirmed an “overweight” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $296.65.
Check Out Our Latest Stock Analysis on THC
Insiders Place Their Bets
In other Tenet Healthcare news, Director Roy Blunt sold 1,000 shares of the stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $293.00, for a total value of $293,000.00. Following the completion of the sale, the director owned 3,589 shares in the company, valued at approximately $1,051,577. This represents a 21.79% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Nadja West sold 1,152 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total value of $298,137.60. Following the sale, the director directly owned 23,653 shares in the company, valued at approximately $6,121,396.40. This represents a 4.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 99,462 shares of company stock worth $27,081,234 in the last three months. 0.97% of the stock is owned by company insiders.
Tenet Healthcare Stock Performance
THC opened at $271.54 on Thursday. The company has a 50 day simple moving average of $268.85 and a two-hundred day simple moving average of $226.26. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.58 and a quick ratio of 1.52. The firm has a market cap of $21.61 billion, a P/E ratio of 7.88, a PEG ratio of 1.51 and a beta of 1.20. Tenet Healthcare Corporation has a 1-year low of $157.58 and a 1-year high of $301.44.
Tenet Healthcare (NYSE:THC – Get Free Report) last announced its quarterly earnings data on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm had revenue of $6.28 billion for the quarter, compared to the consensus estimate of $5.49 billion. During the same period last year, the firm earned $3.70 EPS. The company’s revenue was up 6.5% on a year-over-year basis. Equities analysts forecast that Tenet Healthcare Corporation will post 22.32 earnings per share for the current fiscal year.
About Tenet Healthcare
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Featured Stories
- Five stocks we like better than Tenet Healthcare
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
